Use of the RBANS to Evaluate Cognition in Patients with Schizophrenia and Metabolic Syndrome: a Meta-Analysis of Case-Control Studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of the RBANS to Evaluate Cognition in Patients with Schizophrenia and Metabolic Syndrome: a Meta-Analysis of Case-Control Studies

Published:2021-03-22 Issue: Volume: Page:
ISSN:0033-2720
Container-title:Psychiatric Quarterly
language:en
Short-container-title:Psychiatr Q

Author:

Zheng Wei,Jiang Wen-Long,Zhang Xun,Cai Dong-Bin,Sun Jia-Wei,Yin Fei,Ren Peng-Cheng,Zhao Min,Wu Hua-Wang,Xiang Ying-Qiang,Liang Wan-Nian,Zheng Wei

Funder

Science and Technology Planning Project of Liwan District of Guangzhou

the Guangzhou Clinical Characteristic Technology Project

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1007/s11126-021-09889-9.pdf

Reference50 articles.

1. Huang YQ, Wang Y, Wang H, Liu ZR, Yu X, Yan J, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–24. https://doi.org/10.1016/s2215-0366(18)30511-x.

2. Denis F, Millot I, Abello N, Carpentier M, Peteuil A, Soudry-Faure A. Study protocol: a cluster randomized controlled trial to assess the effectiveness of a therapeutic educational program in oral health for persons with schizophrenia. Int J Ment Heal Syst. 2016;10:65. https://doi.org/10.1186/s13033-016-0096-0.

3. Huang A, Amos TB, Joshi K, Wang L, Nash A. Understanding healthcare burden and treatment patterns among young adults with schizophrenia. J Med Econ. 2018;21(10):1026–35. https://doi.org/10.1080/13696998.2018.1500370.

4. Emsley R, Chiliza B, Asmal L, Harvey BH. The nature of relapse in schizophrenia. BMC Psychiatry. 2013;13:50. https://doi.org/10.1186/1471-244x-13-50.

5. Zheng W, Zhang QE, Cai DB, Yang XH, Ungvari GS, Ng CH, et al. Combination of metformin and lifestyle intervention for antipsychotic-related weight gain: a meta-analysis of randomized controlled trials. Pharmacopsychiatry. 2019;52(1):24–31. https://doi.org/10.1055/s-0044-101466.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated serum IGFBP-1 levels correlate with cognitive deficits in treatment-resistant and chronic medicated schizophrenia patients;Cytokine;2024-10

2. Exploring the relationship between lipid metabolism and cognition in individuals living with stable-phase Schizophrenia: a small cross-sectional study using Olink proteomics analysis;BMC Psychiatry;2024-09-03

3. Exploring current smartphone-based cognitive assessments in schizophrenia and bipolar disorder;Schizophrenia Research: Cognition;2024-09

4. Decreased serum VEGF and NRG1β1 levels in male patients with chronic schizophrenia: VEGF correlation with clinical symptoms and cognitive deficits;Journal of Psychiatric Research;2024-08

5. Comparison of cognitive performance in first-episode drug-naïve schizophrenia, bipolar II disorder, and major depressive disorder patients after treatment;BMC Psychiatry;2024-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3